Bioharvest Sciences Stock Beta
| CNVCF Stock | USD 6.15 0.03 0.49% |
Bioharvest Sciences fundamentals help investors to digest information that contributes to Bioharvest Sciences' financial success or failures. It also enables traders to predict the movement of Bioharvest OTC Stock. The fundamental analysis module provides a way to measure Bioharvest Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bioharvest Sciences otc stock.
Bioharvest |
Bioharvest Sciences OTC Stock Beta Analysis
Bioharvest Sciences' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Bioharvest Sciences Beta | 1.02 |
Most of Bioharvest Sciences' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioharvest Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Bioharvest Sciences has a Beta of 1.0219. This is 18.83% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The beta for all United States stocks is notably lower than that of the firm.
Bioharvest Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bioharvest Sciences' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Bioharvest Sciences could also be used in its relative valuation, which is a method of valuing Bioharvest Sciences by comparing valuation metrics of similar companies.Bioharvest Sciences is currently under evaluation in beta category among its peers.
Bioharvest Sciences returns are very sensitive to returns on the market. As the market goes up or down, Bioharvest Sciences is expected to follow.
Bioharvest Fundamentals
| Return On Equity | -63.64 | |||
| Return On Asset | -0.53 | |||
| Profit Margin | (2.69) % | |||
| Operating Margin | (2.45) % | |||
| Current Valuation | 106.97 M | |||
| Shares Outstanding | 460.72 M | |||
| Shares Owned By Insiders | 35.15 % | |||
| Price To Book | 91.96 X | |||
| Price To Sales | 28.13 X | |||
| Revenue | 2.1 M | |||
| Gross Profit | 670 K | |||
| EBITDA | (8.63 M) | |||
| Net Income | (9.83 M) | |||
| Cash And Equivalents | 1.21 M | |||
| Total Debt | 3.97 M | |||
| Debt To Equity | 1.62 % | |||
| Current Ratio | 0.69 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (6.79 M) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 1.02 | |||
| Market Capitalization | 75.88 M | |||
| Total Asset | 10.21 M | |||
| Z Score | 11.4 | |||
| Net Asset | 10.21 M |
About Bioharvest Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bioharvest Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioharvest Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioharvest Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Bioharvest OTC Stock
Bioharvest Sciences financial ratios help investors to determine whether Bioharvest OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioharvest with respect to the benefits of owning Bioharvest Sciences security.